Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
LENZ Therapeutics, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing the first aceclidine-based eye drop to improve vision in patients diagnosed with presbyopia. Its product candidates, LNZ100 and LNZ101, are preservative-free, single-use, once-daily eye d... LENZ Therapeutics, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing the first aceclidine-based eye drop to improve vision in patients diagnosed with presbyopia. Its product candidates, LNZ100 and LNZ101, are preservative-free, single-use, once-daily eye drops containing aceclidine and aceclidine plus brimonidine, respectively. LNZ100 and LNZ101 are under clinical evaluation in the registration-enabling Phase III CLARITY trials as potential therapies for the treatment of presbyopia, a condition impacting an estimated 1.8 billion people globally and 128 million people in the United States. Mostrar más
| Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
|---|---|---|---|---|---|---|---|---|
| 1 | 4.375 | 18.9969604863 | 23.03 | 28.32 | 22.64 | 190719 | 25.24937037 | CS |
| 4 | 1.455 | 5.60693641618 | 25.95 | 28.32 | 16.535 | 283786 | 22.45194606 | CS |
| 12 | 2.325 | 9.27033492823 | 25.08 | 28.32 | 16.535 | 208578 | 23.57133763 | CS |
| 26 | 2.635 | 10.6378683892 | 24.77 | 38.93 | 16.535 | 180701 | 26.52481844 | CS |
| 52 | 11.505 | 72.358490566 | 15.9 | 38.93 | 14.42 | 179530 | 23.270355 | CS |
| 156 | 11.425 | 71.4956195244 | 15.98 | 38.93 | 14.42 | 174045 | 23.08004773 | CS |
| 260 | 11.425 | 71.4956195244 | 15.98 | 38.93 | 14.42 | 174045 | 23.08004773 | CS |
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones
Hot Features
Premium
